Related content

Particle therapy: a suitable alternative to stereotactic body radiotherapy for stage I non-small-cell lung cancer?

By Shibamoto Yuta  

Lung Cancer Management, Vol. 2, Iss. 5, 2013-10 ,pp. : 353-356

Future Medicine

Access to resources Recommend Favorite

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer

By          

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 840-844

Spandidos Publications

Access to resources Recommend Favorite

Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation

By Hodge Wes   Tomé Wolfgang   Jaradat Hazim   Orton Nigel   Khuntia Deepak   Traynor Anne   Weigel Tracey   Mehta Minesh  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 890-896

Informa Healthcare

Access to resources Recommend Favorite

Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries

By Baumann Pia   Nyman Jan   Lax Ingmar   Friesland Signe   Hoyer Morten   Rehn Ericsson Suzanne   Johansson Karl-Axel   Ekberg Lars   Morhed Elisabeth   Paludan Merete   Wittgren Lena   Blomgren Henrik   Lewensohn Rolf  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 787-795

Informa Healthcare

Access to resources Recommend Favorite

Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency?

By Paludan Merete   Traberg Hansen Anders   Petersen Jørgen   Grau Cai   Høyer Morten  

Acta Oncologica, Vol. 45, Iss. 7, 2006-09 ,pp. : 818-822

Informa Healthcare

Access to resources Recommend Favorite